Associate Professor Winston Liauw is a medical oncologist and clinical pharmacologist and currently practices both of these disciplines. He has completed a Masters degree in pharmaceutical development. His clinical practice is based around gastrointestinal cancer with a speciality in regional and intraperitoneal chemotherapy for peritoneal surface malignancy. His research interests are based around pharmaceutical development and he is currently a principal or co-investigator on numerous industry and investigator initiated clinical trials including phase 1 research. In this capacity he has provided consulting services for the biotechnology industry and contract research organisations. He has been heavily involved in research ethics and regulation and is chair of the Cancer Institute NSW Human Research Ethics Committee (Clinical Trials)e. In 2010 he was appointed to the board of directors of the NPS Better Choices > Better Health. He has published the results of clinical trials, cancer outcomes research, on adverse event reporting in clinical trials and the review of clinical trial protocols. A/Prof Liauw‘s other interests include medical education and the use of information technology in medicine.
Abstracts this author is presenting: